Kamlesh Darji/X
Aug 26, 2026, 17:52
Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
Kamlesh Darji, Senior Resident in the Department of Pathology at AIIMS (All India Institute of Medical Sciences), shared a post on X:
“He four core patterns
- Prolonged APTT with normal PT : hemophilia A/B, factor 11 or 12 deficiency, lupus anticoagulant; vWD may prolong APTT if factor 8 is reduced
- Prolonged PT with normal APTT : factor 7 deficiency, early warfarin effect, early vitamin K deficiency, early liver disease
- Both PT and APTT prolonged : DIC, severe liver disease, severe vitamin K deficiency, common pathway factor deficiency
- Both PT and APTT normal with bleeding : platelet function disorder, mild vWD, factor 13 deficiency, vascular disorder
Mixing study: The Splitter
- Corrects on mixing : factor deficiency
- Does not correct on mixing : inhibitor such as lupus anticoagulant or specific factor inhibitor
- Factor 8 inhibitor : may initially correct but fail to correct after incubation because the inhibitor is time dependent
Platelet disorders
- Low platelets with large young platelets and normal/increased marrow megakaryocytes : immune thrombocytopenia
- Low platelets with schistocytes and normal coagulation tests : TTP or HUS
- Low platelets with schistocytes and deranged coagulation tests : DIC
- Platelet fall typically 5–10 days after heparin with thrombosis : heparin-induced thrombocytopenia
- Usually normal platelet count with reduced VWF antigen/activity : von Willebrand disease
- Reduced ristocetin-induced platelet agglutination corrected by normal plasma : von Willebrand disease
- Reduced ristocetin-induced platelet agglutination not corrected by normal plasma : Bernard-Soulier syndrome
- Normal ristocetin response with defective aggregation to ADP, epinephrine and collagen : Glanzmann thrombasthenia
- Giant platelets with thrombocytopenia : Bernard-Soulier syndrome
- Small platelets with eczema and immunodeficiency : Wiskott-Aldrich syndrome
Factor deficiencies
- Factor 8 deficiency : hemophilia A, X-linked
- Factor 9 deficiency : hemophilia B, X-linked
- Factor 11 deficiency : hemophilia C, classically associated with Ashkenazi Jewish ancestry
- Factor 12 deficiency : markedly prolonged APTT without clinical bleeding
- Factor 13 deficiency : normal PT and APTT with delayed bleeding; diagnose with factor 13 activity assay
- Vitamin K-dependent factors : 2, 7, 9, 10, protein C and protein S
- Shortest half-life among vitamin K-dependent clotting factors : factor 7, therefore PT rises first
Highest Yield Information
- Warfarin-induced skin necrosis : rapid fall in protein C, especially in underlying protein C deficiency
- Arterial or venous thrombosis with recurrent pregnancy morbidity : antiphospholipid syndrome
- Prolonged APTT that fails to correct on mixing with thrombosis : lupus anticoagulant
- Thrombosis with intravascular hemolysis and cytopenias : paroxysmal nocturnal hemoglobinuria
- Heparin resistance : consider antithrombin deficiency, although several acquired causes also occur
- Homocystinuria with thrombosis : cystathionine beta-synthase deficiency
Thank you for reading.
Follow me for more posts. All the best.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question